25 results
8-K
EX-10.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any
S-3/A
EX-99.1
BBLG
Bone Biologics Corp
17 Jan 24
Shelf registration (amended)
5:21pm
of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
8-K
EX-10.1
jptlj 2l3grr95u61jut
20 Nov 23
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:46am
8-K
EX-1.1
x5ucs 5ckjoeoziq56
11 Oct 22
Bone Biologics Prices $5,100,000 Underwritten Public Offering
4:59pm
424B4
x1nynu mjdt42
11 Oct 22
Prospectus supplement with pricing info
10:57am
424B5
3y8vcxl78lskv67
2 Nov 21
Prospectus supplement for primary offering
3:50pm
424B4
bnzs50swjg0ffxkm jc
15 Oct 21
Prospectus supplement with pricing info
6:07am
424B4
vx8k8f387xbv
15 Oct 21
Prospectus supplement with pricing info
6:06am
8-K
EX-1.1
mpgyoemqwgnjmyx8ry
15 Oct 21
Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split
6:05am